Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 101

1.

Bicaudal D2 is a novel autoantibody target in systemic sclerosis that shares a key epitope with CENP-A but has a distinct clinical phenotype.

Fritzler MJ, Hudson M, Choi MY, Mahler M, Wang M, Bentow C, Milo J, Baron M; Canadian Scleroderma Research Group.

Autoimmun Rev. 2018 Mar;17(3):267-275. doi: 10.1016/j.autrev.2018.01.006. Epub 2018 Jan 31. Review.

PMID:
29369808
2.

A comparison of health-related quality of life (HRQoL) across four systemic autoimmune rheumatic diseases (SARDs).

Greenfield J, Hudson M, Vinet E, Fortin PR, Bykerk V, Pineau CA, Wang M, Bernatsky S, Baron M; Canadian Scleroderma Research Group and Canadian Inflammatory Myopathy Study Group.

PLoS One. 2017 Dec 19;12(12):e0189840. doi: 10.1371/journal.pone.0189840. eCollection 2017.

3.

Assessment of English-French differential item functioning of the Satisfaction with Appearance Scale (SWAP) in systemic sclerosis.

Jewett LR, Kwakkenbos L, Hudson M, Baron M, Thombs BD; Canadian Scleroderma Research Group.

Body Image. 2017 Sep;22:97-102. doi: 10.1016/j.bodyim.2017.06.005. Epub 2017 Jul 13.

PMID:
28711486
4.

Antifibrillarin Antibodies Are Associated with Native North American Ethnicity and Poorer Survival in Systemic Sclerosis.

Mejia Otero C, Assassi S, Hudson M, Mayes MD, Estrada-Y-Martin R, Pedroza C, Mills TW, Walker J, Baron M, Stevens W, Proudman SM, Nikpour M, Mehra S, Wang M, Fritzler MJ; Canadian Scleroderma Research Group; Australian Scleroderma Cohort Study; Genetics versus Environment in Scleroderma Outcome Study.

J Rheumatol. 2017 Jun;44(6):799-805. doi: 10.3899/jrheum.160574. Epub 2017 Apr 1.

5.

Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort.

Nevskaya T, Baron M, Pope JE; Canadian Scleroderma Research Group.

Rheumatology (Oxford). 2017 Jul 1;56(7):1111-1122. doi: 10.1093/rheumatology/kex015.

PMID:
28340090
6.

Relationship between calcium channel blockers and skin fibrosis in patients with systemic sclerosis.

Li G, Adachi JD, Cheng J, Thabane L, Hudson M, Fritzler MJ, Lorenzi S, Baron M, Larché M; Canadian Scleroderma Research Group.

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):56-60. Epub 2017 Jan 31.

PMID:
28229818
7.

Early Mortality in a Multinational Systemic Sclerosis Inception Cohort.

Hao Y, Hudson M, Baron M, Carreira P, Stevens W, Rabusa C, Tatibouet S, Carmona L, Joven BE, Huq M, Proudman S, Nikpour M; Canadian Scleroderma Research Group; Australian Scleroderma Interest Group.

Arthritis Rheumatol. 2017 May;69(5):1067-1077. doi: 10.1002/art.40027. Epub 2017 Apr 6.

8.

Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues.

Richard N, Hudson M, Gyger G, Baron M, Sutton E, Khalidi N, Pope JE, Carrier N, Larché M, Albert A, Fortin PR, Thorne C, Masetto A; on the behalf of Canadian Scleroderma Research Group.

Rheumatology (Oxford). 2017 Apr 1;56(4):581-588. doi: 10.1093/rheumatology/kew441.

PMID:
28013205
9.

The association of sociodemographic and objectively-assessed disease variables with fatigue in systemic sclerosis: an analysis of 785 Canadian Scleroderma Research Group Registry patients.

Levis B, Kwakkenbos L, Hudson M, Baron M, Thombs BD; and the Canadian Scleroderma Research Group.

Clin Rheumatol. 2017 Feb;36(2):373-379. doi: 10.1007/s10067-016-3501-9. Epub 2016 Dec 10.

PMID:
27943045
10.

Anti-HMGCR antibodies in systemic sclerosis.

Hudson M, Luck Y, Stephenson M, Choi MY, Wang M, Baron M, Fritzler MJ; Canadian Scleroderma Research Group (CSRG).

Medicine (Baltimore). 2016 Nov;95(44):e5280.

11.

Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations.

Hoa S, Hudson M, Troyanov Y, Proudman S, Walker J, Stevens W, Nikpour M, Assassi S, Mayes MD, Wang M, Baron M, Fritzler MJ; Canadian Scleroderma Research Group (CSRG); Australian Scleroderma Interest Group (ASIG); Genetics versus Environment in Scleroderma Outcome Study (GENISOS).

Medicine (Baltimore). 2016 Aug;95(35):e4713. doi: 10.1097/MD.0000000000004713.

12.

Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study.

Valenzuela A, Baron M; Canadian Scleroderma Research Group, Herrick AL, Proudman S, Stevens W; Australian Scleroderma Interest Group, Rodriguez-Reyna TS, Vacca A, Medsger TA Jr, Hinchcliff M, Hsu V, Wu JY, Fiorentino D, Chung L.

Semin Arthritis Rheum. 2016 Dec;46(3):344-349. doi: 10.1016/j.semarthrit.2016.05.008. Epub 2016 Jun 2.

13.

Summed and Weighted Summary Scores for the Medsger Disease Severity Scale Compared with the Physician's Global Assessment of Disease Severity in Systemic Sclerosis.

Harel D, Hudson M, Iliescu A, Baron M; Canadian Scleroderma Research Group, Steele R.

J Rheumatol. 2016 Aug;43(8):1510-8. doi: 10.3899/jrheum.151440. Epub 2016 Jun 15.

PMID:
27307525
14.

The Impact of Pain and Itch on Functioning and Health-Related Quality of Life in Systemic Sclerosis: An Exploratory Study.

Racine M, Hudson M, Baron M, Nielson WR; Canadian Scleroderma Research Group.

J Pain Symptom Manage. 2016 Jul;52(1):43-53. doi: 10.1016/j.jpainsymman.2015.12.314. Epub 2016 Feb 11.

PMID:
26876159
15.

Development and Validation of the Body Concealment Scale for Scleroderma.

Jewett LR, Malcarne VL, Kwakkenbos L, Harcourt D, Rumsey N, Körner A, Steele RJ, Hudson M, Baron M, Haythornthwaite JA, Heinberg L, Wigley FM, Thombs BD; Canadian Scleroderma Research Group.

Arthritis Care Res (Hoboken). 2016 Aug;68(8):1158-65. doi: 10.1002/acr.22819.

16.

Using Marital Status and Continuous Marital Satisfaction Ratings to Predict Depressive Symptoms in Married and Unmarried Women With Systemic Sclerosis: A Canadian Scleroderma Research Group Study.

Levis B, Rice DB, Kwakkenbos L, Steele RJ, Hagedoorn M, Hudson M, Baron M, Thombs BD; Canadian Scleroderma Research Group.

Arthritis Care Res (Hoboken). 2016 Aug;68(8):1143-9. doi: 10.1002/acr.22802.

17.

Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects.

Wodkowski M, Hudson M, Proudman S, Walker J, Stevens W, Nikpour M, Assassi S, Mayes MD, Tatibouet S, Wang M; Canadian Scleroderma Research Group (CSRG); Australian Scleroderma Interest Group (ASIG); Genetics versus Environment in Scleroderma Outcome Study (GENISOS), Baron M, Fritzler MJ.

Autoimmunity. 2015;48(8):542-51. doi: 10.3109/08916934.2015.1077231. Epub 2015 Aug 31.

PMID:
26334795
18.

Monospecific anti-Ro52/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival.

Wodkowski M, Hudson M, Proudman S, Walker J, Stevens W, Nikpour M, Assassi S, Mayes MD, Wang M, Baron M, Fritzler MJ; Canadian Scleroderma Research Group (CSRG); Australian Scleroderma Cohort Study (ASCS); Genetics versus Environment in Scleroderma Outcome Study (GENISOS).

Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S131-5. Epub 2015 Aug 27.

PMID:
26315678
19.

Can the Cancer-related Fatigue Case-definition Criteria Be Applied to Chronic Medical Illness? A Comparison between Breast Cancer and Systemic Sclerosis.

Kwakkenbos L, Minton O, Stone PC, Alexander S, Baron M, Hudson M, Thombs BD; Canadian Scleroderma Research Group.

J Rheumatol. 2015 Jul;42(7):1156-62. doi: 10.3899/jrheum.141421. Epub 2015 Jun 1.

PMID:
26034154
20.

Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.

Srivastava N, Hudson M, Tatibouet S, Wang M, Baron M, Fritzler MJ; Canadian Scleroderma Research Group (CSRG).

Semin Arthritis Rheum. 2015 Oct;45(2):184-9. doi: 10.1016/j.semarthrit.2015.04.009. Epub 2015 Apr 10.

PMID:
25959492

Supplemental Content

Loading ...
Support Center